202 related articles for article (PubMed ID: 38049961)
1. Cerebral vascular and blood brain-barrier abnormalities in a mouse model of epilepsy and tuberous sclerosis complex.
Guo D; Zhang B; Han L; Rensing NR; Wong M
Epilepsia; 2024 Feb; 65(2):483-496. PubMed ID: 38049961
[TBL] [Abstract][Full Text] [Related]
2. Rapamycin prevents epilepsy in a mouse model of tuberous sclerosis complex.
Zeng LH; Xu L; Gutmann DH; Wong M
Ann Neurol; 2008 Apr; 63(4):444-53. PubMed ID: 18389497
[TBL] [Abstract][Full Text] [Related]
3. Tsc2 gene inactivation causes a more severe epilepsy phenotype than Tsc1 inactivation in a mouse model of tuberous sclerosis complex.
Zeng LH; Rensing NR; Zhang B; Gutmann DH; Gambello MJ; Wong M
Hum Mol Genet; 2011 Feb; 20(3):445-54. PubMed ID: 21062901
[TBL] [Abstract][Full Text] [Related]
4. The specificity and role of microglia in epileptogenesis in mouse models of tuberous sclerosis complex.
Zhang B; Zou J; Han L; Beeler B; Friedman JL; Griffin E; Piao YS; Rensing NR; Wong M
Epilepsia; 2018 Sep; 59(9):1796-1806. PubMed ID: 30079598
[TBL] [Abstract][Full Text] [Related]
5. Microglial activation during epileptogenesis in a mouse model of tuberous sclerosis complex.
Zhang B; Zou J; Han L; Rensing N; Wong M
Epilepsia; 2016 Aug; 57(8):1317-25. PubMed ID: 27263494
[TBL] [Abstract][Full Text] [Related]
6. Inflammatory mechanisms contribute to the neurological manifestations of tuberous sclerosis complex.
Zhang B; Zou J; Rensing NR; Yang M; Wong M
Neurobiol Dis; 2015 Aug; 80():70-9. PubMed ID: 26003087
[TBL] [Abstract][Full Text] [Related]
7. A circuitry and biochemical basis for tuberous sclerosis symptoms: from epilepsy to neurocognitive deficits.
Feliciano DM; Lin TV; Hartman NW; Bartley CM; Kubera C; Hsieh L; Lafourcade C; O'Keefe RA; Bordey A
Int J Dev Neurosci; 2013 Nov; 31(7):667-78. PubMed ID: 23485365
[TBL] [Abstract][Full Text] [Related]
8. The natural history and treatment of epilepsy in a murine model of tuberous sclerosis.
Erbayat-Altay E; Zeng LH; Xu L; Gutmann DH; Wong M
Epilepsia; 2007 Aug; 48(8):1470-6. PubMed ID: 17484760
[TBL] [Abstract][Full Text] [Related]
9. Postnatal reduction of tuberous sclerosis complex 1 expression in astrocytes and neurons causes seizures in an age-dependent manner.
Zou J; Zhang B; Gutmann DH; Wong M
Epilepsia; 2017 Dec; 58(12):2053-2063. PubMed ID: 29023667
[TBL] [Abstract][Full Text] [Related]
10. Enhanced epidermal growth factor, hepatocyte growth factor, and vascular endothelial growth factor expression in tuberous sclerosis complex.
Parker WE; Orlova KA; Heuer GG; Baybis M; Aronica E; Frost M; Wong M; Crino PB
Am J Pathol; 2011 Jan; 178(1):296-305. PubMed ID: 21224066
[TBL] [Abstract][Full Text] [Related]
11. Epileptogenesis and reduced inward rectifier potassium current in tuberous sclerosis complex-1-deficient astrocytes.
Jansen LA; Uhlmann EJ; Crino PB; Gutmann DH; Wong M
Epilepsia; 2005 Dec; 46(12):1871-80. PubMed ID: 16393152
[TBL] [Abstract][Full Text] [Related]
12. Early developmental electroencephalography abnormalities, neonatal seizures, and induced spasms in a mouse model of tuberous sclerosis complex.
Rensing N; Johnson KJ; Foutz TJ; Friedman JL; Galindo R; Wong M
Epilepsia; 2020 May; 61(5):879-891. PubMed ID: 32274803
[TBL] [Abstract][Full Text] [Related]
13. Modulation of astrocyte glutamate transporters decreases seizures in a mouse model of Tuberous Sclerosis Complex.
Zeng LH; Bero AW; Zhang B; Holtzman DM; Wong M
Neurobiol Dis; 2010 Mar; 37(3):764-71. PubMed ID: 20045054
[TBL] [Abstract][Full Text] [Related]
14. Hypothalamic orexin and mechanistic target of rapamycin activation mediate sleep dysfunction in a mouse model of tuberous sclerosis complex.
Zhang B; Guo D; Han L; Rensing N; Satoh A; Wong M
Neurobiol Dis; 2020 Feb; 134():104615. PubMed ID: 31605778
[TBL] [Abstract][Full Text] [Related]
15. Intermittent dosing of rapamycin maintains antiepileptogenic effects in a mouse model of tuberous sclerosis complex.
Rensing N; Han L; Wong M
Epilepsia; 2015 Jul; 56(7):1088-97. PubMed ID: 26122303
[TBL] [Abstract][Full Text] [Related]
16. Impaired astrocytic gap junction coupling and potassium buffering in a mouse model of tuberous sclerosis complex.
Xu L; Zeng LH; Wong M
Neurobiol Dis; 2009 May; 34(2):291-9. PubMed ID: 19385061
[TBL] [Abstract][Full Text] [Related]
17. Mechanistic target of rapamycin (mTOR) in tuberous sclerosis complex-associated epilepsy.
Curatolo P
Pediatr Neurol; 2015 Mar; 52(3):281-9. PubMed ID: 25591831
[TBL] [Abstract][Full Text] [Related]
18. Neuronal and glia abnormalities in Tsc1-deficient forebrain and partial rescue by rapamycin.
Carson RP; Van Nielen DL; Winzenburger PA; Ess KC
Neurobiol Dis; 2012 Jan; 45(1):369-80. PubMed ID: 21907282
[TBL] [Abstract][Full Text] [Related]
19. TORC1-dependent epilepsy caused by acute biallelic Tsc1 deletion in adult mice.
Abs E; Goorden SM; Schreiber J; Overwater IE; Hoogeveen-Westerveld M; Bruinsma CF; Aganović E; Borgesius NZ; Nellist M; Elgersma Y
Ann Neurol; 2013 Oct; 74(4):569-79. PubMed ID: 23720219
[TBL] [Abstract][Full Text] [Related]
20. Sirolimus relieves seizures and neuropsychiatric symptoms via changes of microglial polarity in tuberous sclerosis complex model mice.
Koike-Kumagai M; Fujimoto M; Wataya-Kaneda M
Neuropharmacology; 2022 Nov; 218():109203. PubMed ID: 35931213
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
